Researchers assessed the effectiveness of both sofosbuvir/velpatasvir and gelcaprevir/pibrentasvir among patients infected with hepatitis C genotype 6.
Researchers assessed the effect of preoperative antiviral treatment for hepatitis C virus on the risk for surgical-related complications in patients who underwent total joint arthroplasty.
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Researchers assessed whether the rate of treatment initiations for hepatitis C virus infection among patients participating in a methadone treatment program increased after the implementation of a hepatology clinic.
Researchers conducted a study to determine whether the addition of a default screening order in the electronic health record increases the rate of hepatitis C virus screening among hospitalized patients.
Investigators conducted a study to determine the effect of syringes with fixed needles vs those with detachable needles on the risk for hepatitis C virus transmission among people who use injectable drugs.
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
Investigators assessed the safety and efficacy of a minimal monitoring approach to delivering treatment for hepatitis C virus infection.
The 2022 child and adolescent immunization schedule summarizes ACIP recommendations, including several changes.
Investigators assessed whether chronic hepatitis C virus infection is associated with a higher incidence of esophageal cancer.
From 2002 to 2018, there was an increase in the prevalence of comorbid chronic conditions among cancer survivors.
Investigators assessed virological, biochemical, and clinical outcomes following cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.
Researchers conducted a study to determine the association between Fc gamma RIIb expression concentrations and chronic hepatitis B virus infection progression.
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
The COVID-19 pandemic and opioid crisis created new barriers to HCV treatment, leading to the lowest annual treatment rate in 5 years.
Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.
The approval was based on data from a phase 2b study which evaluated Zepatier in 22 patients aged 12 to less than 18 years.
PreHevbrio contains the small (S), middle (pre-S2) and large (pre-S1) hepatitis B surface antigens.
The application submission is supported by data from the ongoing phase 3 MYR301 study, along with completed and ongoing phase 2 studies.